Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA; Churg–Strauss syndrome) is a rare, systemic, necrotizing, small-sized vessel vasculitis. It most typically affects middle-aged individuals who have developed late-onset asthma then more characteristic vasculitis manifestations, like fever, skin lesions (40–75 % of the patients, mainly purpura, often necrotic, and/or cutaneous nodules or papules and sometimes migratory urticarial rashes) and/or mononeuritis multiplex. Blood and tissue eosinophilia, especially the lungs, gastrointestinal tract, and heart, is a hallmark of the disease. Biopsy of an affected organ or lesions, especially skin lesions, can help in making the diagnosis, when showing eosinophilic and/or granulomatous vasculitis, with or without necrosis. Antineutrophil cytoplasm autoantibodies (ANCA) can be detected in nearly 40 % of the patients. Differential diagnoses include drug-induced and hypersensitivity vasculitis, parasitic infections, and hypereosinophilic syndromes. Treatment relies on systemic corticosteroids, combined with an immunosuppressant for severe and/or life-threatening forms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Churg J, Strauss L. Allergic angiitis and periarteritis nodosa. Am J Pathol. 1951;27:277–301.
Pagnoux C, Guillevin L. Churg–Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol. 2010;22:21–8.
Sinico RA, Bottero P. Churg–Strauss angiitis. Best Pract Res Clin Rheumatol. 2009;23:355–66.
Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg–Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78:26–37.
Keogh KA, Specks U. Churg–Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med. 2003;115:284–90.
Sablé-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome. Ann Intern Med. 2005;143:632–8.
Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss syndrome. Arthritis Rheum. 2005;52:2926–35.
Davis MD, Daoud MS, McEvoy MT, Su WP. Cutaneous manifestations of Churg–Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol. 1997;37:199–203.
Finan MC, Winkelmann RK. The cutaneous extravascular necrotizing granuloma (Churg–Strauss granuloma) and systemic disease: a review of 27 cases. Medicine (Baltimore). 1983;62:142–58.
Pagnoux C, Kluger N, Francès C, Guillevin L. Cutaneous granulomatous vasculitis and extravascular granulomas. Expert Rev Dermatol. 2006;1:315–26.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pagnoux, C., Guillevin, L. (2014). Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss Syndrome). In: Matucci-Cerinic, M., Furst, D., Fiorentino, D. (eds) Skin Manifestations in Rheumatic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7849-2_36
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7849-2_36
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7848-5
Online ISBN: 978-1-4614-7849-2
eBook Packages: MedicineMedicine (R0)